A Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.
Clinical trial NCT07743944 · RECRUITING
Trial details
- NCT number
- NCT07743944
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-05
- Primary completion
- 2031-08-04
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.